Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (DE:J7Z)
FRANKFURT:J7Z
Jazz Pharmaceuticals (J7Z) Ownership Overview
3.30% Insiders
29.59% Mutual Funds
34.94% Other Institutional Investors
27.46% ETFs
4.71% Public Companies and Individual Investors
The ownership structure of Jazz Pharmaceuticals (DE:J7Z) stock is a mix of institutional, retail, and individual investors. Approximately 91.99% of the company’s stock is owned by Institutional Investors, 3.30% is owned by Insiders, and 4.71% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 03, 2025 | Patricia Carr Svp & Cao | xxxxxxxxxxxxx | $805809 |
| Mar 03, 2025 | Neena M Patil Evp & Clo | xxxxxxxxxxxxx | $550506 |
| Sep 11, 2024 | Mary Elizabeth Henderson Svp Tech. Op | xxxxxxxxxxxxx | $152703 |
| May 07, 2024 | Neena M Patil Evp & Clo | xxxxxxxxxxxxx | $548250 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $5295 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $88668 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1858456 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $5112572 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,540,025 | Institution | 9.12% | 792,583,677 | |
| 5,409,026 | Institution | 8.91% | 773,842,305 | |
| 5,140,646 | Institution | 8.46% | 735,446,520 | |
| 2,228,500 | Institution | 3.67% | 318,820,353 | |
| 1,900,000 | Institution | 3.13% | 271,823,500 | |
| 1,274,248 | Institution | 2.10% | 182,300,290 | |
| 1,176,106 | Insider | 1.94% | 168,259,605 | |
| 1,085,860 | Institution | 1.79% | 155,348,561 | |
| 1,069,721 | Institution | 1.76% | 153,039,635 | |
| 924,998 | Institution | 1.52% | 132,334,839 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,140,646 | Institution | 8.46% | 735,446,520 | |
| 1,900,000 | Institution | 3.13% | 271,823,500 | |
| 924,998 | Institution | 1.52% | 132,334,839 | |
| 913,177 | Institution | 1.50% | 130,643,668 | |
| 897,662 | Institution | 1.48% | 128,424,014 | |
| 855,847 | Institution | 1.41% | 122,441,751 | |
| 619,571 | Institution | 1.02% | 88,638,925 | |
| 595,340 | Institution | 0.98% | 85,172,317 | |
| 421,794 | Institution | 0.69% | 60,343,959 | |
| 370,429 | Institution | 0.61% | 52,995,425 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Jazz Pharmaceuticals (DE:J7Z)?
According to the latest TipRanks data, approximately 34.94% of the company's stock is held by institutional investors, 3.30% is held by insiders, and 4.71% is held by retail investors.
What percentage of Jazz Pharmaceuticals (DE:J7Z) stock is held by institutional investors?
According to the latest TipRanks data, approximately 34.94% of Jazz Pharmaceuticals (DE:J7Z) stock is held by institutional investors.
What percentage of Jazz Pharmaceuticals (DE:J7Z) stock is held by retail investors?
According to the latest TipRanks data, approximately 4.71% of Jazz Pharmaceuticals (DE:J7Z) stock is held by retail investors.
Who owns the most shares of Jazz Pharmaceuticals (DE:J7Z)?
Vanguard owns the most shares of Jazz Pharmaceuticals (DE:J7Z).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.